Patent details
EP3953711 Title: LATERAL FLOW IMMUNOASSAY FOR MEASURING FUNCTIONAL C1-ESTERASE INHIBITOR (C1-INH) IN PLASMA SAMPLES
Basic Information
- Publication number:
- EP3953711
- PCT Application Number:
- US2020027406
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207228966
- PCT Publication Number:
- WO2020210446
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LATERAL FLOW IMMUNOASSAY FOR MEASURING FUNCTIONAL C1-ESTERASE INHIBITOR (C1-INH) IN PLASMA SAMPLES
- French Title of Invention:
- DOSAGE IMMUNOLOGIQUE D'ÉCOULEMENT LATÉRAL POUR MESURER L'INHIBITEUR FONCTIONNEL DE C1-ESTERASE (C1-INH) DANS DES ÉCHANTILLONS DE PLASMA
- German Title of Invention:
- LATERAL-FLOW-IMMUNASSAY ZUR MESSUNG DES FUNKTIONALEN C1-ESTERASE-INHIBITORS (C1-INH) IN PLASMAPROBEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/03/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/04/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 26/02/2025
- Unitary Effect Registration Date:
- 02/04/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 09/04/2020
- Grant date:
- 26/02/2025
- EP Publication Date:
- 16/02/2022
- PCT Publication Date:
- 15/10/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/02/2025
- EP B1 Publication Date:
- 26/02/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/04/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/02/2025
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi,, Osaka 541-0045, Japan (JP)
Inventor
1
- Name:
- CHOCKALINGAM, Priya, Sethu
- Address:
- United States (US)
2
- Name:
- ZHOU, Zhiwei
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962833235 P
- Priority Date:
- 12/04/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 201962930615 P
- Priority Date:
- 05/11/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- G01N 33/573; G01N 33/543; G01N 33/558;
Publication
European Patent Bulletin
1
- Issue number:
- 202509
- Publication date:
- 26/02/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202514
- Publication date:
- 02/04/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202518
- Publication date:
- 30/04/2025
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202519
- Publication date:
- 07/05/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|